Laura J. Esserman, MD, MBA (1); Ian M. Thompson, Jr, MD (2); Brian Reid, MD, PhD (3)
(1) University of California, San Francisco
(2) University of Texas Health Science Center at San Antonio
(1) University of California, San Francisco
(2) University of Texas Health Science Center at San Antonio
(3) Fred Hutchinson Cancer Research Center, Seattle, Washington
JAMA. 2013;310(8):797-798. doi:10.1001/jama.2013.108415.
RASTER文獻下載
乳癌亞型基因檢測幫助判斷早期乳癌患者做前置式(術前)輔助治療是否有好處
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Stefan Glück, Femke de Snoo, Justine Peeters,Lisette Stork-Sloots, George Somlo
Breast Cancer Research Treatment 2013 Jun;139(3):759-67
文獻下載
Dr. Stefan Glück 解說乳癌亞型如何影響個人化治療